CIK 0001764013
- Large accelerated filer
Immunovant, Inc.
Sign in to watch- Ticker
- IMVT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 832771572
- Phone
- +1 917-410-3120
- Business address
- 1000 PARK FORTY PLAZA, DURHAM, NC, 27713
- Former names
- Health Sciences Acquisitions Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $895,852
- in 9 filings, $173K under 10b5-1 plans
Net −$895,852. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-12-01 | MIGAUSKY GEORGE V Director | Sale 10b5-1 | −4,200 | $38.79 | $163K | 118,308 |
| 2023-12-01 | MIGAUSKY GEORGE V Director | Sale 10b5-1 | −3,478 | $39.81 | $138K | 114,830 |
| 2023-12-01 | MIGAUSKY GEORGE V Director | Sale 10b5-1 | −5,022 | $40.46 | $203K | 109,808 |
| 2023-11-22 | Salzmann Peter Chief Executive Officer | Sale | −15,601 | $32.75 | $511K | 949,125 |
| 2023-11-22 | Salzmann Peter Chief Executive Officer | Sale | −616 | $33.52 | $21K | 948,509 |
| 2023-11-22 | Barnett Eva Renee Chief Financial Officer | Sale | −3,901 | $32.75 | $128K | 327,019 |
| 2023-11-22 | Barnett Eva Renee Chief Financial Officer | Sale | −154 | $33.52 | $5K | 326,865 |
| 2023-11-22 | Butchko Julia G. Chief Development Officer | Sale | −3,141 | $32.75 | $103K | 411,384 |
| 2023-11-22 | Butchko Julia G. Chief Development Officer | Sale | −124 | $33.52 | $4K | 411,260 |
| 2023-11-22 | Macias William L. Chief Medical Officer | Sale | −3,141 | $32.75 | $103K | 333,721 |
| 2023-11-22 | Macias William L. Chief Medical Officer | Sale | −124 | $33.52 | $4K | 333,597 |
| 2023-11-22 | Levine Mark S. Chief Legal Officer | Sale | −3,128 | $32.75 | $102K | 307,253 |
| 2023-11-22 | Levine Mark S. Chief Legal Officer | Sale | −124 | $33.52 | $4K | 307,129 |
| 2023-10-25 | Levine Mark S. Chief Legal Officer | Sale | −4,107 | $34.66 | $142K | 310,381 |
| 2023-10-19 | Macias William L. Chief Medical Officer | Sale | −530 | $36.80 | $20K | 336,862 |
| 2023-10-10 | Barnett Eva Renee Chief Financial Officer | Sale | −4,557 | $36.92 | $168K | 330,920 |
| 2023-10-05 | Butchko Julia G. Chief Development Officer | Sale | −296 | $35.54 | $11K | 415,964 |
| 2023-10-05 | Butchko Julia G. Chief Development Officer | Sale | −1,439 | $36.39 | $52K | 414,525 |
| 2023-10-05 | Salzmann Peter Chief Executive Officer | Sale | −894 | $35.54 | $32K | 969,071 |
| 2023-10-05 | Salzmann Peter Chief Executive Officer | Sale | −4,345 | $36.39 | $158K | 964,726 |
Page 16 of 18 · 351 trades